Dr. Douglas Evans | Surgery | Best Researcher Award

Dr. Douglas Evans, Medical College of Wisconsin, United States

Dr. Douglas B. Evans is a distinguished leader in surgical oncology and currently serves as Chair of the Department of Surgery at the Medical College of Wisconsin. His medical expertise focuses on pancreatic cancer and complex surgical oncology, where he has made significant contributions through his leadership and research. He is highly respected for his extensive work at prestigious institutions, including the University of Texas MD Anderson Cancer Center, where he previously held a tenured professorship. Dr. Evans’ commitment to advancing cancer research and improving patient care has earned him recognition nationally and internationally. He has served on multiple national advisory boards and contributed to various scientific committees. Dr. Evans’ work continues to impact the fields of surgery and oncology, enhancing the understanding and treatment of pancreatic cancer.

Professional Profile

scopus

google scholar

Summary of Suitability for the Research for Best Researcher Award

Dr. Douglas B. Evans, with his extensive background in surgical oncology and a distinguished career, is highly suited for the Research for Best Researcher Award. His leadership as Chair of the Department of Surgery at the Medical College of Wisconsin since 2009 demonstrates his commitment to advancing surgical practices and medical education. His impressive list of academic and clinical roles, including his tenure as a professor at the University of Texas M. D. Anderson Cancer Center, highlights his sustained contributions to the field of cancer research, particularly in pancreatic and thyroid cancers.

Education

Dr. Douglas B. Evans received his foundational education at Oliver Ames High School in North Easton, Massachusetts. He then attended Bates College in Lewiston, Maine, where he earned his Bachelor of Science degree. His medical journey continued at Boston University School of Medicine, where he obtained his M.D. Following this, Dr. Evans pursued postgraduate training in surgery at Dartmouth-Hitchcock Medical Center, where he completed both his internship and residency in general surgery. His specialization in surgical oncology was honed during his fellowship at the University of Texas MD Anderson Cancer Center. This extensive academic background provided him with the expertise required to become a leading figure in the surgical treatment of pancreatic and gastrointestinal cancers. His licensures include multiple states such as Texas and Wisconsin, and he is board-certified by the American Board of Surgery, with recertifications reflecting his continued commitment to excellence in surgical practice.

Experience

Dr. Douglas B. Evans has an extensive career in surgical oncology, marked by significant leadership roles. He began as an Instructor in Surgery at Dartmouth Medical School and progressed to Teaching Associate at the University of Texas MD Anderson Cancer Center. At MD Anderson, Dr. Evans ascended from Assistant Professor to full Professor of Surgery, eventually securing the Hamill Foundation Distinguished Professorship in honor of Dr. Richard G. Martin, Sr. Since 2009, he has been the Chair of the Department of Surgery at the Medical College of Wisconsin, where he also holds the Ausman Family Foundation Chair. Dr. Evans’ career highlights include serving as Surgeon-in-Chief at Froedtert Hospital and contributing to numerous advisory boards and national committees. His experience and influence in academic surgery, particularly in pancreatic cancer research and treatment, have established him as a key figure in the surgical oncology field.

Awards and Honors

Dr. Douglas B. Evans has received numerous awards and honors throughout his distinguished career in surgical oncology. Early recognition came with the Resident’s Publication Award in 1985, followed by the prestigious Thomas P. Almy Award in 1987. His dedication to teaching was acknowledged by multiple Outstanding Teacher Awards, notably in 1995 and 2003 at the University of Texas MD Anderson Cancer Center. In 1999, he was awarded the American College of Surgeons Traveling Fellowship. More recently, Dr. Evans was honored with the Andrew L. Warshaw Master Educator Award in 2014 from the Society for Surgery of the Alimentary Tract, as well as the Wisconsin Way Award in Medicine in 2018. In 2021, he was appointed to the Douglas B. Evans Chair for Surgical Research, a testament to his contributions to both clinical practice and academic surgery. In 2023, he received the Benjamin E. Mays Medal from Bates College, their highest alumni honor.

Research Focus

Dr. Douglas B. Evans’ research primarily focuses on the surgical treatment of pancreatic cancer and complex gastrointestinal cancers. His work has significantly advanced the understanding of pancreatic tumor biology and the development of surgical techniques to improve patient outcomes. He is particularly interested in translational research that bridges basic science discoveries and clinical applications. Dr. Evans has contributed to groundbreaking studies on the molecular mechanisms driving pancreatic cancer, enhancing the accuracy of surgical interventions and postoperative care. His research has been pivotal in the development of multi-disciplinary treatment approaches that combine surgery with chemotherapy and radiation therapy for pancreatic and other gastrointestinal cancers. As a renowned leader in his field, Dr. Evans has published extensively in high-impact medical journals, and his research efforts continue to shape the landscape of surgical oncology and improve the prognosis for cancer patients worldwide.

Publication Top Notes

One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
- Citation: 5547
Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement
- Citation: 1921
Medullary thyroid cancer: management guidelines of the American Thyroid Association
- Citation: 1712
Cancer-associated stromal fibroblasts promote pancreatic tumor progression
- Citation: 1310
Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy
- Citation: 1012

David Monroy, University of Miami, United States

David Monroy is a dedicated researcher with a strong background in neurocritical care and ophthalmology research. A graduate of Florida International University with a Bachelor of Science in Biological Sciences, David has developed significant expertise through his involvement in cutting-edge research projects. He has contributed to impactful studies at the University of Miami’s Neurology and Bascom Palmer Eye Institute, co-authoring numerous publications in esteemed journals. His focus on ocular surface tumors and brain injury has earned him recognition in the medical research community. David is passionate about scientific discovery and its real-world applications, aiming to bridge the gap between research and patient care. He is currently expanding his knowledge in traumatic brain injuries and their long-term outcomes through ongoing projects. His collaborative spirit and dedication to ethical research practices have positioned him as a promising young researcher in the medical field.

Professional Profile

orcid

Education :

David Monroy earned his Bachelor of Science in Biological Sciences from Florida International University (FIU) in 2020, where he followed a pre-medical track. As a student at FIU, David participated in various research programs, including the SEA-PHAGES program, where he discovered and analyzed novel bacteriophages. His educational journey was marked by an honors-level academic experience, which equipped him with the critical thinking and technical skills necessary for scientific research. Additionally, his time at FIU fostered a deep interest in neurobiology and medical sciences, which laid the groundwork for his subsequent research into neurocritical care and ophthalmology. Throughout his studies, David developed a comprehensive understanding of biological systems, disease mechanisms, and medical treatments, all while maintaining a high standard of academic achievement. His undergraduate experiences have significantly influenced his career trajectory in medical research.

Experience :

David Monroy’s research career includes notable roles such as Neurocritical Care Research Associate at the University of Miami, where he currently supports clinical studies in the neurosurgical intensive care unit. His work involves ensuring adherence to ethical protocols, communicating with patient families, and contributing to impactful studies on traumatic brain injury. Previously, David participated in ophthalmology research at the Bascom Palmer Eye Institute, focusing on ocular surface tumors and diagnostic techniques. He has authored multiple manuscripts and presented research findings at conferences, demonstrating his ability to communicate complex data effectively. During his time at Florida International University, he interned in a Parkinson’s disease research lab, where he gained experience in laboratory techniques and the study of neurodegenerative diseases. David’s career reflects a commitment to advancing medical knowledge through both clinical and basic science research, with a focus on improving patient care outcomes.

Awards and Honors :

David Monroy’s research and academic excellence have earned him several accolades. His work at the University of Miami’s Department of Neurology has been recognized for its contributions to understanding traumatic brain injuries, leading to multiple poster presentations at the prestigious Neurocritical Care Society conferences. Additionally, his studies on ocular surface tumors at the Bascom Palmer Eye Institute have resulted in peer-reviewed publications and presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference. David’s commitment to advancing scientific knowledge has been rewarded with co-authorship on high-impact medical papers, underscoring his role in groundbreaking discoveries. While at Florida International University, he was part of the honors college, a testament to his academic dedication. His volunteer efforts, particularly with underserved communities, have also been recognized, reflecting his commitment to both research and service.

Research Focus :

David Monroy’s research is primarily focused on neurocritical care and ophthalmology, with an emphasis on traumatic brain injury and ocular surface tumors. In neurocritical care, his work has centered on understanding the cognitive and motor dissociation in brain injury patients, as well as examining the causes of traumatic brain injuries across different demographics. His research aims to improve long-term patient outcomes through innovative treatments and monitoring techniques. In ophthalmology, David has explored the infectious etiology of conjunctival tumors and developed diagnostic modalities for ocular surface squamous neoplasia. His research seeks to enhance early detection and improve therapeutic interventions for patients with ocular diseases. By collaborating with multidisciplinary teams, David continues to contribute to research that bridges the gap between laboratory findings and clinical applications, ensuring that his work has a tangible impact on patient care.

Publication Top notes :

📘 Alvarez OP., Monroy D., Thura S., et al. Infectious Etiology of Conjunctival Tumors. Expert Review of Ophthalmology, 2024.
👁️ Monroy D., Venkateswaran N., Matthews JL., et al. Conjunctival keratoacanthoma: a clinical and histopathological case series. Canadian Journal of Ophthalmology, 2024.
🔬 Monroy D., Serrano A., Galor A., & Karp CL. Medical treatments for ocular surface squamous neoplasia. Eye, 2023.
💀 Monroy D., Garcia J., Zarate SD., et al. Displaced humeral pathological fracture secondary to intraosseous hemangioma. Radiology Case Reports, 2022.